The role of the central renin-angiotensin system in Parkinson’s disease

Angiotensin II Type 2 Receptor Stimulation

(2008) Elena Kaschina et al.   CIRCULATION

Brain renin angiotensin in disease

(2008) M. Ian Phillips et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Genetic polymorphism of Angiotensin-Converting Enzyme is not associated with the development of Parkinson's disease and of l-dopa-induced adverse effects

(2008) Esterina Pascale et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS

(2008) J. Rodriguez-Pallares et al.   NEUROBIOLOGY OF DISEASE

Use of antihypertensives and the risk of Parkinson disease

(2008) C. Becker et al.   NEUROLOGY

Excess Salt Causes Cerebral Neuronal Apoptosis and Inflammation in Stroke-Prone Hypertensive Rats Through Angiotensin II-Induced NADPH Oxidase Activation

(2008) Eiichiro Yamamoto et al.   STROKE

Protective effect of captopril and enaraprilat, angiotensin-converting enzyme inhibitors, on para-nonylphenol-induced OH generation and dopamine efflux in rat striatum

(2008) Toshio Obata et al.   TOXICOLOGY

Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression

(2007) Changping Hu et al.   ATHEROSCLEROSIS